TOWA PHARMACEUTICAL CO.,LTD. [4553.T]
TOKYO, Jun 24 (Pulse News Wire) – Towa Pharmaceutical CO.,LTD. (4553.T) announced changes to its board of directors effective June 24, following resolutions made at its annual shareholders' meeting and subsequent board session held .
Key appointments include: - Reappointment of Yoshida Itsuro as President and CEO. - Promotion of Nakamura Hideo to director. - Reappointment of several existing directors: Ukawa Osamu, Takeyasu Masahiro, Kokubun Tokizane, Eiki Norikazu, Tanaka Masao, Oishi Kaori, Gotō Kenryō, and Andō Nobuki.
- Appointment of Taniguchi Muneyasu as a new outside director. Additionally, Yoshida Itsuro, Ukawa Osamu, Takeyasu Masahiro, Kokubun Tokizane, and Nakamura Hideo have been designated as responsible officers under the Pharmaceuticals and Medical Devices Act. This restructuring reflects ongoing efforts to strengthen governance and leadership within the organization.
🟡 Confidence: Standard AI-translated content.